08:13 AM EST, 11/15/2024 (MT Newswires) -- Danaher's ( DHR ) Cepheid subsidiary is being urged by global health groups to reduce the price of its GeneXpert mpox test to $5 from $20 to improve access in low-income nations, media outlets reported Friday.

The World Health Organization declared mpox a global public health emergency this summer as an outbreak in the Democratic Republic of Congo began spreading to neighboring countries, according to the reports.

GeneXpert is one of the three mpox tests approved for emergency use by the WHO. This test is crucial because machines that process the results are available across Africa, the reports said.

Danaher ( DHR ) previously reduced its tuberculosis test prices to $7.97 last year following pressure from activists, Reuters said.

Cepheid did not immediately respond to MT Newswires' request for comment.

Price: 237.76, Change: -1.62, Percent Change: -0.68